U.S. Markets close in 1 hr 48 mins

Zynerba Pharma Looks Like Bad Medicine for Investors

Zynerba Pharma Looks Like Bad Medicine for Investors

Jim Cramer is wary of Zynerba Pharmaceuticals . "No. If you want this, you want GW Pharmaceuticals ," said Cramer to a caller during the Lightning Round of his "Mad Money" program on Monday. In this daily bar chart of ZYNE, below, we can see that prices quietly bottomed around $3 in late December.